HomePSTX • NASDAQ
add
Poseida Therapeutics Inc
Previous close
$2.97
Day range
$2.86 - $3.02
Year range
$1.83 - $4.27
Market cap
281.65M USD
Avg Volume
384.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 25.97M | 29.78% |
Operating expense | 54.57M | 22.75% |
Net income | -31.37M | -14.26% |
Net profit margin | -120.78 | 11.96% |
Earnings per share | -0.32 | 0.00% |
EBITDA | -30.41M | -14.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 237.81M | 10.81% |
Total assets | 298.69M | 6.21% |
Total liabilities | 237.87M | 63.02% |
Total equity | 60.82M | — |
Shares outstanding | 97.12M | — |
Price to book | 4.71 | — |
Return on assets | -28.29% | — |
Return on capital | -50.63% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -31.37M | -14.26% |
Cash from operations | 38.45M | 215.44% |
Cash from investing | -61.20M | -242.09% |
Cash from financing | 0.00 | — |
Net change in cash | -22.75M | -332.95% |
Free cash flow | 6.14M | 144.48% |
About
Founded
2014
Website
Employees
337
